 |
Optos P200MA Contributes to Major Diabetic Research Study LONDON, UK, 02 May 2008 – Optos plc (LSE: OPTS), a leading medical technology company for the design, development, manufacturing and marketing of retinal imaging devices, is today announcing that the more…
NicOx Announces U.S. Phase 2a Results For PF-03187207 And Gives An Update On Continuing NO-Prostaglandin Program NicOx S.A. (Euronext Paris: COX) today announced the results of a U.S. phase 2 study, conducted by its partner Pfizer Inc, which compared the safety and efficacy of various doses of PF-03187207 to more…
National Non-Profit, EyeCare America, Announces Its First Ever 'EyeRide For Sight' EyeCare America, a public service program of the Foundation of the American Academy of Ophthalmology, today announced that six cyclists will embark on a transcontinental bike ride in order to educate more…
Statins Linked With Neuroprotection Statin drugs could act as a neuroprotective agent for glaucoma suspect patients, preventing progression of optic nerve head parameters, a study found. Shan C. Lin, MD, and colleagues conducted more…
Cell's 'power Plant' Genes Raise Vision Disorder Risk Genetic variation in the DNA of mitochondria – the “power plants” of cells – contributes to a person’s risk of developing age-related macular degeneration (AMD), Vanderbilt investigators report May 7 more…
Vitamin E Offers No Protection From Cataracts BOSTON, May 1 -- Ten years of vitamin E supplements were associated with no effect on cataract development among middle-age and older women, researchers here found. Among 37,675 participants in the more…
QLT Completes Enrollment In The RADICAL Study QLT Inc. (NASDAQ: QLTI; TSX: QLT) today announced it has completed enrolling 160 patients in the Company's Phase II RADICAL trial to determine if combination therapy with Visudyne(R) more…
Incoming ASCRS President Calls For Innovation In Education, Advocacy CHICAGO — The American Society of Cataract and Refractive Surgery must sustain the momentum of its impact by continually introducing innovation to its education and advocacy efforts, said incoming more…
Pupil Size Differences Noted with Moxifloxacin and Gatifloxacin Before Eye Surgery: Presented At ARVO FORT LAUDERDALE, Fla -- May 5, 2008 -- Patients who are treated with the antibiotic moxifloxacin 0.5% before having cataract surgery appear to have a significant reduction in pupil size, while there more…
Endoscopic Corneal Video Features Groundbreaking Imaging FORT LAUDERDALE, Fla. — A team of researchers is seeking to advance ophthalmic imaging through the use of three- and four-dimensional endoscopic confocal renderings of the cornea after corneal inlay more…
New Test For Peak IOP Is Faster, Easier, Researcher Says FORT LAUDERDALE, Fla. — A 5-minute provocative test that inverts a patient's body 30° is as good as a standard water drinking test in detecting peak IOP in glaucoma patients, according to a poster more…
|
|
|
Foldable Toric Intraocular Lens for Astigmatism Correction in Cataract Patients more…
Intraocular Pressure Measurements Following Descemet Stripping Endothelial Keratoplasty more…
Correlations between Corneal Hysteresis, Intraocular Pressure, and Corneal Central Pachymetry more…
Stability of Laser Epithelial Keratomileusis with and without Mitomycin C Performed to Correct Myopia in Thin Corneas: A 15-Month Follow-up more…
Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management more…
The Comparative Effectiveness and Cost-Effectiveness of Vitreoretinal Interventions more…
|
|
